Sar-Arg-Val-Tyr-Val-His-NH2 from MedChemExpress

Sar-Arg-Val-Tyr-Val-His-NH2 is a G_q-biased agonists, exhibits 10-fold larger molecular efficacies at the AT₁R-Gq fusion protein compared with the AT₁R-βarr2 fusion protein